OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-β type I receptor

Chuannan Fan(Oncode Institute), Peter ten Dijke(Leiden University Medical Center)
Signal Transduction and Targeted Therapy
April 29, 2022
Cited by 61


Related Papers